Years Active: 2023
Title: Maxime Laugier: Innovator in Diabetes Treatment
Introduction
Maxime Laugier is a notable inventor based in Royat, France. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of diabetes. His innovative approach has led to the development of a unique film-coated tablet that addresses this critical health issue.
Latest Patents
Laugier holds a patent for a film-coated tablet comprising a triazine derivative for use in the treatment of diabetes. This invention involves a film-coated tablet that features an inner core and an external coating. The inner core contains a high proportion of a specific triazine derivative, namely 2-amino-3,6-dihydro-4-dimethylamino-6-methyl-1,3,5-triazine, along with pharmaceutically acceptable salts and a specific binder. The patent also outlines the use of these tablets in treating diabetes and its complications. Furthermore, it describes a specific manufacturing process for these film-coated tablets, which includes a granulation step in a high-shear mixer.
Career Highlights
Throughout his career, Maxime Laugier has focused on innovative solutions in the pharmaceutical industry. His work has been instrumental in advancing treatment options for diabetes, showcasing his commitment to improving patient outcomes.
Collaborations
Laugier has collaborated with Sébastien Bolze, contributing to the development and refinement of his patented invention. Their partnership has played a crucial role in bringing this innovative treatment to fruition.
Conclusion
Maxime Laugier's contributions to diabetes treatment through his patented film-coated tablet exemplify the impact of innovation in healthcare. His work continues to inspire advancements in pharmaceutical solutions for chronic conditions.